Danaher company profile
Company profile
Danaher has 58,000 employees and is headquartered in Washington, United States.
Hospitals, physicians' offices, reference laboratories and other critical care settings are among the customers for the company's clinical instruments, consumables, software and services, which are used to diagnose disease and support treatment decisions. Companies developing and manufacturing therapeutics buy its cell culture media, filtration technologies, chromatography resins, single-use hardware and manufacturing suite design services. Life sciences laboratories use its mass spectrometers, microscopes, flow cytometry and genomics systems, along with antibodies and reagents sold under brands such as ABCAM, BECKMAN COULTER, LEICA MICROSYSTEMS, SCIEX and PALL. Sales are made in the United States, China and other markets abroad.
In the fiscal year ended December 2025, revenue was 24.6 billion USD, up 2.9% from the previous year, and net income was 3.6 billion USD. By region, North America accounted for 42.2% of revenue, High Growth Markets for 28.6%, Western Europe for 24.2% and other developed markets for 5.1%. The company had 58,000 employees and is headquartered in Washington, District of Columbia. It was incorporated in 1969.
Company facts
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Headquarters
- 2200 Pennsylvania Avenue N.W., 20037-1701, Washington
- Employees
- 58,000
- Chief executive
- Julie Montgomery
- Founded
- 1969
- Fiscal year
- January - December
- Listing
- DHR · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US2358511028
- Website
- danaher.com
Danaher and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| DanaherDHR | United States | $163.94B | 58,000 | 22.0% | 38.6 |
| Thermo Fisher ScientificTMO | United States | $259.44B | 125,000 | 19.1% | 36.9 |
| WatersWAT | United States | $90.45B | 15,000 | 16.0% | 192.6 |
| IDEXX LaboratoriesIDXX | United States | $55.48B | 11,000 | 32.5% | 47.0 |
| Agilent TechnologiesA | United States | $49.04B | 18,200 | 24.5% | 34.3 |
| NateraNTRA | United States | $46.27B | 6,135 | -8.5% | — |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
